Peringkat dalam Saham
#16218
Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on... Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.
Harga Saham
$3.70
Terakhir disinkronkan: 2026-07-31
Kapitalisasi Pasar
$305.87M
Perubahan (1 hari)
-3.53%
Perubahan (1 tahun)
203.66%
Perdagangan Opus Genetics, Inc. (IRD)
Harga IRD dengan kapitalisasi pasar B
Kapitalisasi pasar dari Opus Genetics, Inc.(IRD)
Kapitalisasi Pasar: $305.87M
Per September 2026, Opus Genetics, Inc. memiliki kapitalisasi pasar sebesar $305.87M. Ini menjadikan Opus Genetics, Inc. sebagai perusahaan 16218th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Opus Genetics, Inc. dari 2024 hingga 2026
IRD dibandingkan dengan 5 teratas stocks paling populer
| Harga IRD |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.260T
|
+1,719,438.14%
|
|
|
|
|
$4.779T
|
+1,562,157.96%
|
|
|
|
|
$4.017T
|
+1,313,103.81%
|
|
|
|
|
$3.719T
|
+1,215,863.74%
|
|
|
|
|
$2.734T
|
+893,812.25%
|
